Lipid disorders in obesity.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 131, doi. 10.1007/s11906-999-0007-8
- By:
- Publication type:
- Article
Works matching IS 15226417 AND DT 1999 AND VI 1 AND IP 2
Results: 17
1
2
Obesity and cardiovascular hemodynamic function.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 127, doi. 10.1007/s11906-999-0006-9
- By:
- Publication type:
- Article
3
Obesity, hypertension, and sympathetic nervous system activity.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 119, doi. 10.1007/s11906-999-0005-x
- By:
- Publication type:
- Article
4
Obesity, hypertension, and vascular disease.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 140, doi. 10.1007/s11906-999-0009-6
- By:
- Publication type:
- Article
5
Pathology of renal complications in obesity.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 137, doi. 10.1007/s11906-999-0008-7
- By:
- Publication type:
- Article
6
Angiotensin receptors and the kidney.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 117, doi. 10.1007/s11906-999-0003-z
- By:
- Publication type:
- Article
7
New insights into the renin-angiotensin system and hypertensive renal disease.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 187, doi. 10.1007/s11906-999-0017-6
- By:
- Publication type:
- Article
8
Literature alert.
- Published in:
- 1999
- Publication type:
- Abstract
9
Role of nitric oxide in the control of renal function and salt sensitivity.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 178, doi. 10.1007/s11906-999-0016-7
- By:
- Publication type:
- Article
10
Web alert.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 109, doi. 10.1007/s11906-999-0001-1
- Publication type:
- Article
11
Antihypertensive drugs and diabetic nephropathy.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 170, doi. 10.1007/s11906-999-0015-8
- By:
- Publication type:
- Article
12
Novel actions of angiotensin II via its renal type-2 (AT<sub>2</sub>) receptor.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 151, doi. 10.1007/s11906-999-0012-y
- By:
- Publication type:
- Article
13
The kidney as a target of hypertension.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 164, doi. 10.1007/s11906-999-0014-9
- By:
- Publication type:
- Article
14
The epithelial sodium channel in hypertension.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 158, doi. 10.1007/s11906-999-0013-x
- By:
- Publication type:
- Article
15
The salt-blood pressure controversy: What are the issues?
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 149, doi. 10.1007/s11906-999-0011-z
- By:
- Publication type:
- Article
16
Obesity, blood pressure, and renal sodium handling.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 145, doi. 10.1007/s11906-999-0010-0
- By:
- Publication type:
- Article
17
The effects of weight loss and other nonpharmacologic interventions on blood pressure.
- Published in:
- Current Hypertension Reports, 1999, v. 1, n. 2, p. 118, doi. 10.1007/s11906-999-0004-y
- By:
- Publication type:
- Article